Bone injury
Conditions
Interventions
Experimental group:Absorbable bone hemostatic material
Control group:Bone wax
Sponsors
The First Affiliated Hospital of Xi'an Jiaotong University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Age 18-80 years, gender is not limited; 2. Patients with osteoblending caused by osteotomy, drilling or bone cutting; 3. Patients who can understand the purpose of the trial, voluntarily sign an informed consent form, and can be followed up.
Exclusion criteria
Exclusion criteria: 1. Those who have participated in other clinical trials within 3 months before the start of the trial and have not completed other clinical trials; 2. Expected life expectancy of less than 3 months; 3. Infected bone damage surface; 4. Patients with coagulation dysfunction (specifically defined as 1.5 times the upper limit of PT or APTT) ; 5. Those who are pregnant, nursing or unable to use effective contraception and have a childbearing plan within 3 months; 6. Known allergies to this type of product; 7. The researchers judged that the patient's clinical condition was not suitable for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemostasis is effective within 3 minutes; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incision healing time;Hemoglobin;Adverse Events; | — |
Countries
China
Contacts
Public ContactYingang Zhang
Shaanxi Bai Ao Regenerative Medicine Co., Ltd
Outcome results
None listed